Quality improvement guidelines for the treatment of lower extremity deep vein thrombosis with use of endovascular thrombus removal

Journal of Vascular and Interventional Radiology

Volumn 17, Issue 3, 2006, Pages 435-448

  Vedantham, Suresh ^a   Thorpe, Patricia E ^b   Cardella, John F ^c   Grassi, Clement J ^d   Patel, Nilesh H ^e   Ferral, Hector ^e   Hofmann, Lawrence V ^f   Janne D'Othée, Bertrand M ^u   Antonaci, Vittorio P ^g,h   Brountzos, Elias N ⁱ   Brown, Daniel B ^a   Martin, Louis G ^j   Matsumoto, Alan H ^k   Meranze, Steven G ^l   Miller, Donald L ^m   Millward, Steven F ⁿ   Min, Robert J ^o   Neithamer Jr , Calvin D ^p   Rajan, Dheeraj K ^q   Rholl, Kenneth S ^r   Schwartzberg, Marc S ^s   Swan, Timothy L ^t   Towbin, Richard B ^u   Wiechmann, Bret N ^u   Sacks, David ^v   McClenny, Tricia ^u   more..

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f JOHNS HOPKINS HOSPITAL   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^h Charlotte Radiology PA   (United States)

ⁱ UNIVERSITY OF ATHENS   (Greece)

^j EMORY UNIVERSITY HOSPITAL   (United States)

^k UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^l VANDERBILT UNIVERSITY HOSPITAL   (United States)

^m WALTER REED ARMY MEDICAL CENTER   (United States)

ⁿ Peterborough Regional Health Center   (Canada)

^o WEILL CORNELL MEDICAL COLLEGE   (United States)

^p Fairfax Radiological Consultants   (United States)

^q UNIVERSITY OF TORONTO   (Canada)

^r INOVA ALEXANDRIA HOSPITAL   (United States)

^s Radiology Associates of Central Florida   (United States)

^t MARSHFIELD CLINIC   (United States)

^u North Florida Regional Medical Center ^*

^v READING HOSPITAL AND MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; CONTRAST MEDIUM; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; RETEPLASE; STREPTOKINASE; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

BLEEDING; BLOOD CLOT LYSIS; CATHETER; CLINICAL ASSESSMENT; DEEP VEIN THROMBOSIS; DRUG HYPERSENSITIVITY; ENDOVASCULAR SURGERY; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LEG THROMBOSIS; LIFE EXPECTANCY; LIMB SALVAGE; LONG TERM CARE; LUNG EMBOLISM; METHODOLOGY; MORBIDITY; NONHUMAN; PATIENT CARE; PATIENT MONITORING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHLEBOGRAPHY; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; PROTECTIVE CLOTHING; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; STENT; SYMPTOM; THROMBECTOMY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

EID: 33748263008     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000197348.57762.15     Document Type: Article

References (78)

1. Semba CP, Dake MD. Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis. Radiology 1994; 191:487-494.
2. Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 2003; 14:S199-S202.
3. Sherry S. Thrombolytic therapy in thrombosis. NIH Consensus Statement Online 1980; 3:1-6.
4. Porter JM, Rutherford RB, Clagett GP, et al. Reporting standards in venous disease. J Vasc Surg 1988; 8:172-181.
5. Buller HR, Hull RD, Hyers TM, et al. Antithrombotic therapy for venous thromboembolic disease. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:401S-428S.
6. Bookstein JJ, Fellmeth B, Roberts A, et al. Pulsed-spray pharmacomechanical thrombolysis: preliminary clinical results. AJR 1989; 152:1097-1100.
7. Patel N, Sacks D, Patel RI, et al. SIR reporting standards for the treatment of acute limb ischemia with use of transluminal removal of arterial thrombus. J Vasc Interv Radiol 2003; 14:S453-S465.
8. Konstantinides S, Geibel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347:1143-1150.
9. Douglas MG, Sumner DS. Duplex scanning for deep vein thrombosis: has it replaced both phlebography and non-invasive testing? Semin Vasc Surg 1996; 9:3-12.
10. Tick LW, Ton E, van Voorthuizen T, et al. Practical diagnostic management of patients with clinically suspected deep vein thrombosis by clinical probability test, compression ultrasonography, and D-dimer test. Am J Med 2002; 113:630-635.
11. Prandoni P, Bernardi E, Tormene D, et al. Diagnosis of recurrent deep vein thrombosis. Semin Vasc Med 2001; 1:55-60.
12. Quinlan DJ, Alikhan R, Gishen P, Sidhu PS. Variations in lower limb venous anatomy: implications for US diagnosis of deep vein thrombosis. Radiology 2003; 228:443-448.
13. Kamida CB, Kistner RL, Eklof B, Masuda EM. Lower extremity ascending and descending phlebography. In: Gloviczki, P, Yao JST, eds. Handbook of Venous Disorders, 2nd ed: Guidelines of the American Venous Forum. Great Britain: Arnold , 2001; pp. 132-139.
14. Elias A, LeCorff G, Bouvier JL. Value of real-time ultrasound imaging in the diagnosis of deep vein thombosis of the lower limbs. Int Angiol 1987; 6:175-182.
15. Mitchell DC, Grasty MS, Stebbings WSL, et al. Comparison of duplex ultrasonography and venography in the diagnosis of deep venous thrombosis. Br J Surg 1991; 78:611-613.
16. Roh BS, Park KH, Kim EA, et al. Prognostic value of CT before thrombolytic therapy in iliofemoral deep venous thrombosis. JVIR 2002; 13:71-76.
17. Fraser DG, Moody AR, Morgan PS, et al. Diagnosis of lower-limb deep venous thrombosis: a prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med 2002; 136:89-98.
18. Eklof B, Arfvidsson B, Kistner RL, Masuda EM. Indications for surgical treatment of iliofemoral vein thrombosis. Hematol Oncol Clin North Am 2000; 14:471-482.
19. Patel NH, Plorde JJ, Meissner M. Catheter-directed thrombolysis in the treatment of phlegmasia cerulea dolens. Ann Vasc Surg 1998; 12:471-475.
20. Robinson DL, Teitelbaum GP. Phlegmasia cerulea dolens: treatment by pulse-spray and infusion thrombolysis. AJR 1993; 160:1288-1290.
21. Weaver FA, Meacham PW, Adkins RB, Dean RH. Phlegmasia cerulea dolens: therapeutic considerations. South Med J 1988; 81:306-312.
22. Douketis JD, Crowther MA, Foster GA, Ginsberg JS. Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? Am J Med 2001; 110:515-519.
23. Strandness DE, Langlois Y, Cramer M, et al. Long-term sequelae of acute venous thrombosis. JAMA 1983; 250:1289-1292.
24. Delis KT, Bountouroglou D, Mansfield AO. Venous claudication in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life. Ann Surg 2004; 239:118-126.
25. Prandoni P, Lensing AW, Prins MH, et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med 2002; 137:955-960.
26. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125:1-7.
27. Arnesen H, Hoiseth A, Ly B. Streptokinase or heparin in the treatment of deep vein thrombosis. Acta Med Scand 1982; 211:65-68.
28. Elliot MS, Immelman EJ, Jeffery P. A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: an interim report of a prospective trial. Br J Surg 1979; 66:838-843.
29. Watson MI, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev 2004; 1:1-66.
30. Plate G, Eklof B, Norgren L, et al. Venous thrombectomy for iliofemoral venous thrombosis: 10-year results of a prospective randomized study. Eur J Vasc Endovasc Surg 1997; 14:333-343.
31. Eklof B, Kistner RL. Is there a role for thrombectomy in iliofemoral venous thrombosis? Semin Vasc Surg 1996; 9:34-45.
32. Comerota AJ, Throm RC, Mathias S, et al. Catheter-directed thrombolysis of iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg 2000; 32:130-137.
33. AbuRahma AF, Perkins SE, Wulu JT, Ng HK. Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. Ann Surg 2001; 233:752-760.
34. Elsharawy M, Elzayat E. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis: a randomised clinical trial. Eur J Vasc Endovasc Surg 2002; 24:209-214.
35. Killewich LA, Bedford GR, Beach KW, Strandness DE. Spontaneous lysis of deep venous thrombi: rate and outcome. J Vasc Surg 1989; 9:89-97.
36. Mewissen MW, Seabrook GR, Meissner MH, et al. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 1999; 211:39-49.
37. Brandjes DP, Buller HR, Heijboer H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997; 349:759-762.
38. Prandoni P, Lensing AW, Prins MH, et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med 2004; 141:249-256.
39. Markel A, Manzo R, Bergelin RO, Strandness DE. Valvular reflux after deep vein thrombosis: incidence and time of occurrence. J Vasc Surg 1992; 15:377-384.
40. Meissner MH, Manzo RA, Bergeline RO, et al. Deep venous insufficiency: the relationship of lysis and subsequent reflux. J Vasc Surg 1993; 18:596-608.
41. Nazarian GK, Austin WR, Wegryn SA, et al. Venous recanalization by metallic stents after failure of balloon angioplasty or surgery: four-year experience. Cardiovasc Intervent Radiol 1996; 19:227-233.
42. O'Sullivan GJ, Semba CP, Bittner CA, et al. Endovascular management of iliac vein compression (May-Thurner) syndrome. J Vasc Interv Radiol 2000; 11:823-836.
43. Raju S, McAllister S, Neglen P. Recanalization of totally occluded iliac and adjacent venous segments. J Vasc Surg 2002; 36:903-911.
44. Cragg AH. Lower extremity deep venous thrombolysis: a new approach to obtaining venous access. JVIR 1996; 7:283-288.
45. Saarinen JP, Domonyi K, Zeitlin R, Salenius JP. Postthrombotic syndrome after isolated calf deep venous thrombosis: the role of popliteal reflux. J Vasc Surg 2002; 36:959-964.
46. Chang R, Cannon RO, Chen CC, et al. Daily catheter-directed single dosing of t-PA in treatment of acute deep venous thrombosis of the lower extremity. J Vasc Interv Radiol 2001; 12:247-252.
47. Goldhaber SZ, Buring JE, Lipnick RJ, Hennekens CH. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med 1984; 76:393-397.
48. O'Meara JJ, McNutt RA, Evans AT, et al. A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis. N Engl J Med 1994; 330:1864-1869.
49. Schwieder G, Grimm W, Siemens HJ, et al. Intermittent regional therapy with rt-PA is not superior to systemic thrombolysis in deep vein thrombosis (DVT): a German multicenter trial. Thromb Haemost 1995; 74:1240-1243.
50. Schweizer J, Kirch W, Koch R, et al. Short- and long-term results after thrombolytic treatment of deep venous thrombosis. J Am Coll Cardiol 2000; 36:1336-1343.
51. Bjarnason H, Kruse JR, Asinger DA, et al. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol 1997; 8:405-418.
52. Raju S, Fountain T, McPherson SH. Catheter-directed thrombolysis for deep venous thrombosis. J Miss State Med Assoc 1998; 39:81-84.
53. Patel NH, Stookey KR, Ketcham DB, Cragg AH. Endovascular management of acute extensive iliofemoral deep venous thrombosis caused by May-Thurner syndrome. J Vasc Interv Radiol 2000; 11:1297-1302.
54. Kasirajan K, Gray B, Ouriel K. Percutaneous Angiojet thrombectomy in the management of extensive deep venous thrombosis. J Vasc Interv Radiol 2001; 12:179-185.
55. Shortell CK, Queiroz R, Johansson M, et al. Safety and efficacy of limited-dose tissue plasminogen activator in acute vascular occlusion. J Vasc Surg 2001; 34:854-859.
56. Vedantham S, Vesely TM, Parti N, et al. Lower extremity venous thrombolysis with adjunctive mechanical thrombectomy. J Vasc Interv Radiol 2002; 13:1001-1008.
57. Sugimoto K, Hofmann LV, Razavi MK, et al. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions. J Vasc Surg 2003; 37:512-517.
58. Grunwald MR, Hofmann LV. Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosis. J Vasc Interv Radiol 2004; 15:347-352.
59. Vedantham S, Vesely TM, Sicard GA, et al. Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vasc Interv Radiol 2004; 15:565-574.
60. Ouriel K, Katzen B, Mewissen M, et al. Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study. J Vasc Interv Radiol 2000; 11:849-854.
61. Castaneda F, Li R, Young K, et al. Catheter-directed thrombolysis in deep venous thrombosis with use of reteplase: immediate results and complications from a pilot study. J Vasc Interv Radiol 2002; 13:577-580.
62. Razavi MK, Wong H, Kee ST, et al. Initial clinical results of tenecteplase (TNK) in catheter-directed thrombolytic therapy. J Endovasc Ther 2002; 9(5):593-598.
63. The STILE Investigators. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg 1994; 220:251-166.
64. Burkart DJ, Borsa JJ, Anthony JP, Thurlo SR. Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study. J Vasc Interv Radiol 2003; 14:729-733.
65. Sharafuddin MJ, Sun S, Hoballah JJ, et al. Endovascular management of venous thrombotic and occlusive diseases of the lower extremities. J Vasc Interv Radiol 2003; 14:405-423.
66. Uflacker R. Mechanical thrombectomy in acute and subacute thrombosis with use of the Amplatz device: arterial and venous applications. J Vasc Interv Radiol 1997; 8:923-932.
67. Delomez M, Beregi J, Willoteaux S, et al. Mechanical thrombectomy in patients with deep venous thrombosis. Cardiovasc Interv Radiol 2001; 24:42-48.
68. Raju S, Owen S Jr., Neglen P. The clinical impact of iliac venous stents in the management of chronic venous insufficiency. J Vasc Surg 2002; 35:8-15.
69. Forauer AR, Gemmette JJ, Dasika NL, et al. Intravascular ultrasound in the diagnosis and treatment of iliac vein compression (May-Thurner) syndrome. J Vasc Interv Radiol 2002; 13:523-527.
70. Semba CP, Dake MD. Catheter-directed thrombolysis for iliofemoral venous thrombosis. Semin Vasc Surg 1996; 9:26-33.
71. Andrews RT, Venbrux AC, Magee CA, Bova DA. Placement of a flexible endovascular stent across the femoral joint: an in vivo study in the swine model. J Vasc Interv Radiol 1999; 10:1219-1228.
72. May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombus of the pelvic veins. Angiology 1957; 8:419-427.
73. Mickley V, Schwagierek R, Rilinger N, et al. Left iliac venous thrombosis caused by venous spur: treatment with thrombectomy and stent implantation. J Vasc Surg 1998; 28:492-497.
74. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 1998; 338:409-416.
75. Imanaka S, Aihara S, Yoshihara K, et al. Use of a temporary caval filter in a young man with pulmonary embolism to prevent migration of massive caval thrombus during an attempt of caval thrombolysis. J Atheroscler Thromb 2000; 6:18-21.
76. Hirsh J, Lee AYY. How we diagnose and treat deep vein thrombosis. Blood 2002; 99:3102-3110.
77. Horne MK, Mayo DJ, Cannon RO, et al. Intraclot recombinant tissue plasminogen activator in the treatment of deep venous thrombosis of the lower and upper extremities. Am J Med 2000; 108:251-255.
78. Verhaeghe R, Stockx, Lacroix H, Vermylen J, Baert AL. Catheter-directed lysis of iliofemoral vein thrombosis with use of rt-PA. Eur Radiol 1997; 7:996-1001.